EY Canada named Jessica Hu of GBM Health Holding Ltd. an EY Entrepreneur Of The Year® 2026 Pacific finalist in the Science and Technology category. For GBM, the recognition marks an important stage in the company’s evolution from an operating diagnostics business into a growing health platform connecting research, commercialization and international market access.
Geno10X Biosciences, Gene Bio Medical and Simon Fraser University researchers are collaborating on an R&D program exploring a point-of-care platform that combines sensitive HPV urine testing with AI-supported risk assessment. Innovate BC awarded C$300,000 to the collaboration, while a separate C$225,000 NSERC Alliance project supports related SFU-led sensor research.
Gene Bio Medical and Bidiphar signed a memorandum of understanding to explore a diagnostics joint venture in Vietnam. The relationship developed after a Team Canada Trade Mission supported by the Trade Commissioner Service and CanExport SMEs. The MOU represents a strategic pathway—not evidence that GBM currently operates a factory or completed joint venture in Vietnam.
From February 3 to 11, 2026, Jessica Hu represented GBM Health Group on the Asia Pacific Foundation of Canada’s Canadian Women-only Business Mission to the Philippines and Singapore. The program combined B2B matchmaking, company presentations, institutional visits and networking, concluding in Singapore alongside CIAC2026 and CanWIN’s investor forum.
Jessica Hu was included in the EY Entrepreneurial Winning Women™ North America Class of 2025. EY’s official page lists her with Gene Biotechnology Enterprises Ltd. and profiles Gene Bio Medical’s work in molecular diagnostics, research, manufacturing and commercialization.
GBM’s Asia E-Commerce Operations Centre is a strategic platform for cross-border sales and multi-channel market development. It is designed to connect digital commerce, distribution, institutional pathways and brand-led consumer engagement through a coordinated regional operating framework.
